Clinical Trials Browser

Suspended × Interleukin-2 × Breast × Clear all

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00673829 2016-06-17

Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

Phase 1 Suspended

26 enrolled

Breast

Breast Neoplasms